Joseph Rabinowitz, PhD

Vice President, Process Sciences

Joseph Rabinowitz is the Vice President of Process Sciences at Kriya Therapeutics. He has more than 20 years of experience in the development of AAV vectors. Previously, Dr. Rabinowitz was the Senior Director of Capsid Development at Pfizer in the Rare Disease Research Unit where he led a team generating AAV viral libraries. Prior to working at Pfizer, he was a member of the faculty at Temple University and Thomas Jefferson University.

Dr. Rabinowitz received his PhD in genetics from Case Western Reserve University and completed his postdoctoral fellowship in Gene Therapy at the University of North Carolina at Chapel Hill. He received his undergraduate degree in Microbiology from the University of Arizona, Tucson.